CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 5,960,103 Value ($000) $25,032 Avg Close — Range —
Q1 2022
Shares 862,383 Value ($000) $4,026 Avg Close — Range —
Q4 2021
Shares 89,090 Value ($000) $221 Avg Close — Range —
Q4 2016
Shares 150,000 Value ($000) $60 Avg Close — Range —